Capabilities and Facilities
ANSTO LifeSciences has a range of capabilities and facilities available, including laboratories and equipment for synthetic chemistry, radiochemistry and radionuclide development, pharmacology and functional imaging.
Synthetic chemistry
ANSTO LifeSciences' synthetic chemistry capabilites and facilities are dedicated to research and development in organic chemistry, with a primary focus on organic compounds for radiochemistry applications
Radiochemistry
ANSTO LifeSciences has capabilities and facilities for radiochemistry research and development including the development of radioligands for imaging such as PET and SPECT and targeted radioisotope therapy.
Radionuclide research and development
ANSTO LifeSciences' radionuclide development capabilities and facilities allow us to develop radionuclide techniques, support internal and external partners, investigate radionuclide generator technologies and develop quality control and assurance technologies.
Radiotracer characterisation and pharmacology
ANSTO LifeSciences' radiotracer characterisation and pharmacology capabilities and facilities include capabilities for evaluating novel compounds or radiotracers for their ability to target tissues of interest. Using comprehensive and up-to-date in vitro and in vivo screening methods, we are able to validate novel radiolabelled or unlabelled compounds.
Preclinical exploration
ANSTO LifeSciences has capabilities and facilities for pre-clinical in vivo exploration, which aims to evaluate and map physiological parameters in specific conditions and assess their changes over time, during disease onset, progression, or recovery through therapy.